首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1361764

全球慢性骨盆疼痛治療市場報告

Global Chronic Pelvic Pain Treatment Market Report

出版日期: 2023年10月01日 | 出版商:

Value Market Research | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2030 年，全球慢性骨盆疼痛治療市場的市場規模將從 2022 年的 89.2 億美元達到近 147.2 億美元，2023-2030 年研究期間年複合成長率為 5.72%。

慢性骨盆腔疼痛 (CPP) 是指肚臍下方和臀部之間區域的疼痛，持續六個月以上或更長時間。慢性骨盆腔疼痛主要由骨盆腔手術、癌症（卵巢、子宮等）和懷孕併發症引起。慢性骨盆腔疼痛通常與行為、認知和情緒後果以及下泌尿道和骨盆底或婦科功能障礙的症狀有關。慢性骨盆腔疼痛治療旨在減輕慢性骨盆疼痛的症狀並提高生活品質。

市場動態：

全球對各種可減輕骨盆疼痛的治療和藥物的需求一直在上升，並繼續推動慢性骨盆疼痛治療市場的銷售。慢性骨盆疼痛診斷的創新增加了慢性骨盆疼痛治療產品的市場價值。此外，有效管理策略的可用性推動了慢性骨盆疼痛治療市場的成長。此外，人們對慢性骨盆疼痛 (CPP) 治療和管理方案範圍的認知不斷增強，可能很快就會帶來利潤豐厚的市場機會。此外，各種健康營、政府策略和旨在傳播骨盆疼痛治療意識的措施也在擴大市場。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球慢性骨盆疼痛治療市場的各個細分市場進行了包容性評估。慢性骨盆疼痛治療產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的慢性骨盆疼痛治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。慢性骨盆疼痛治療市場的主要參與者包括拜耳公司、Becton、Dickinson and Company、葛蘭素史克公司、Hospiinz、Intuitive Surgical、MAST PAK SURGICAL CORP、Mayne Pharma Group Limited、美敦力、Perrigo Company plc。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：慢性骨盆疼痛治療公司的競爭格局

慢性骨盆腔疼痛治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Bayer AG Becton

公司簡介
公司收入
產品
最近的發展

Dickinson and Company

公司簡介
公司收入
產品
最近的發展

GlaxoSmithKline plc.

公司簡介
公司收入
產品
最近的發展

Hospiinz

公司簡介
公司收入
產品
最近的發展

Intuitive Surgical

公司簡介
公司收入
產品
最近的發展

MAST PAK SURGICAL CORP

公司簡介
公司收入
產品
最近的發展

Mayne Pharma Group Limited

公司簡介
公司收入
產品
最近的發展

Medtronic

公司簡介
公司收入
產品
最近的發展

Perrigo Company plc

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11218700

The global demand for Chronic Pelvic Pain Treatment Market is presumed to reach the market size of nearly USD 14.72 BN by 2030 from USD 8.92 BN in 2022 with a CAGR of 5.72% under the study period 2023 - 2030.

Chronic pelvic pain (CPP) is a pain in the area below the belly button and between the hips that lasts more than six months or longer. Chronic pelvic pain is primarily caused by pelvic surgery, cancer (ovarian, uterus, etc.), and pregnancy complications. Chronic pelvic pain is commonly associated with behavioural, cognitive, and emotional consequences and symptoms of the lower urinary tract and pelvic floor or gynaecological dysfunction. Chronic pelvic pain treatment aims to reduce symptoms of chronic pelvic pain and improve quality of life.

MARKET DYNAMICS:

The demand for various treatments and medications that can reduce pelvic pain has been rising globally and continues to fuel sales of the chronic pelvic pain treatment market. The innovations in the diagnosis of chronic pelvic pain increase the market value of chronic pelvic pain treatment products. Moreover, the availability of effective management strategies propels the growth of the chronic pelvic pain treatment market. Additionally, the growing awareness about the range of treatment and management options available for chronic pelvic pain (CPP) will likely offer lucrative market opportunities shortly. Furthermore, various health camps, government strategies & initiatives to spread awareness about treatments for pelvic pain are also augmenting the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of chronic pelvic pain treatment. The growth and trends of chronic pelvic pain treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the chronic pelvic pain treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants)
Surgery (Laparoscopic Surgery, Hysterectomy)
Others

By Distribution Channel

Retail Pharmacies & Drug Stores
E-Commerce
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Chronic Pelvic Pain Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Chronic Pelvic Pain Treatment market include Bayer AG, Becton, Dickinson and Company, GlaxoSmithKline plc., Hospiinz, Intuitive Surgical, MAST PAK SURGICAL CORP, Mayne Pharma Group Limited, Medtronic, Perrigo Company plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CHRONIC PELVIC PAIN TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants) Historic and Forecast Sales by Regions
6.5 Surgery (Laparoscopic Surgery, Hysterectomy) Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1 Overview by Distribution Channel
7.2 Historical and Forecast Data
7.3 Analysis by Distribution Channel
7.4 Retail Pharmacies & Drug stores Historic and Forecast Sales by Regions
7.5 E-commerce Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CHRONIC PELVIC PAIN TREATMENT COMPANIES

9.1. Chronic Pelvic Pain Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CHRONIC PELVIC PAIN TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Bayer AG Becton
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Dickinson and Company
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. GlaxoSmithKline plc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Hospiinz
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Intuitive Surgical
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. MAST PAK SURGICAL CORP
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Mayne Pharma Group Limited
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Medtronic
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Perrigo Company plc
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Technology (USD MN)
Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants) Market Sales by Geography (USD MN)
Surgery (Laparoscopic Surgery, Hysterectomy) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by Distribution Channel (USD MN)
Retail Pharmacies & Drug stores Market Sales by Geography (USD MN)
E-commerce Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Chronic Pelvic Pain Treatment Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Chronic Pelvic Pain Treatment Report
Market Research Process
Market Research Methodology
Global Chronic Pelvic Pain Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Technology
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Technology (USD MN)
Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants) Market Sales by Geography (USD MN)
Surgery (Laparoscopic Surgery, Hysterectomy) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Retail Pharmacies & Drug stores Market Sales by Geography (USD MN)
E-commerce Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Companies Market Share Analysis